Aurinia Pharmaceuticals Inc. Annual Costs and Expenses in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Aurinia Pharmaceuticals Inc. quarterly/annual Costs and Expenses history and growth rate from 2019 to 2023.
  • Aurinia Pharmaceuticals Inc. Costs and Expenses for the quarter ending June 30, 2024 was $58.7M, a 1.81% increase year-over-year.
  • Aurinia Pharmaceuticals Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $268M, a 10% increase year-over-year.
  • Aurinia Pharmaceuticals Inc. annual Costs and Expenses for 2023 was $267M, a 8.84% increase from 2022.
  • Aurinia Pharmaceuticals Inc. annual Costs and Expenses for 2022 was $246M, a 8.47% increase from 2021.
  • Aurinia Pharmaceuticals Inc. annual Costs and Expenses for 2021 was $226M, a 46.6% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $267M +$21.7M +8.84% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $246M +$19.2M +8.47% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $226M +$71.9M +46.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $154M +$63.1M +69.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $91.3M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.